128 related articles for article (PubMed ID: 25634825)
21. Comparison of Two Percutaneous Atrial Septal Defect Occluders for Device Healing and Nickel Release in a Chronic Porcine Model.
Jalal Z; Boudjemline Y; Iriart X; Seguela PE; Delmond S; Loyer V; Gonthier D; Bernus O; Durand M; Bordenave L; Thambo JB
J Interv Cardiol; 2020; 2020():8413831. PubMed ID: 32665769
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature.
Crawford GB; Brindis RG; Krucoff MW; Mansalis BP; Carroll JD
Catheter Cardiovasc Interv; 2012 Aug; 80(2):157-67. PubMed ID: 22552868
[TBL] [Abstract][Full Text] [Related]
23. Nickel allergy and the amplatzer septal occluder.
Singh HR; Turner DR; Forbes TJ
J Invasive Cardiol; 2004 Nov; 16(11):681-2. PubMed ID: 15550748
[No Abstract] [Full Text] [Related]
24. Nickel allergy induced systemic reaction to an intracardiac amplatzer device.
Prestipino F; Pragliola C; Lusini M; Chello M
J Card Surg; 2014 May; 29(3):349-50. PubMed ID: 24762035
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of transcatheter closure of atrial septal defects not only in young adults.
Vijarnsorn C; Durongpisitkul K; Chanthong P; Chungsomprasong P; Soongswang J; Loahaprasitiporn D; Nana A; Kurasirikul S; Nimdet K
J Interv Cardiol; 2012 Aug; 25(4):382-90. PubMed ID: 22409656
[TBL] [Abstract][Full Text] [Related]
26. A comparative study of Cardi-O-Fix septal occluder versus Amplatzer septal occluder in percutaneous closure of secundum atrial septal defects.
Saritas T; Kaya MG; Lam YY; Erdem A; Akdeniz C; Demir F; Erol N; Demir H; Celebi A
Catheter Cardiovasc Interv; 2013 Jul; 82(1):116-21. PubMed ID: 21805616
[TBL] [Abstract][Full Text] [Related]
27. Analysis of maximum P-wave duration and dispersion after percutaneous closure of atrial septal defects: comparison of two septal occluders.
Paç FA; Balli S; Topaloğlu S; Ece I; Oflaz MB
Anadolu Kardiyol Derg; 2012 May; 12(3):249-54. PubMed ID: 22381925
[TBL] [Abstract][Full Text] [Related]
28. Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events.
El-Said H; Hegde S; Foerster S; Hellenbrand W; Kreutzer J; Trucco SM; Holzer R; Burch G; Mirani A; Nicolas R; Porras D; Bergersen L; Moore J
Catheter Cardiovasc Interv; 2015 Feb; 85(2):227-33. PubMed ID: 25257700
[TBL] [Abstract][Full Text] [Related]
29. [Factors influencing the choice of atrial septal occluder for transcatheter closure of secundum atrial septal defects].
Zhang YS; Lan BD; Li H; He XM; Dai ZX; Wang HC; Zhang J; Li J; DU YJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Nov; 37(11):981-5. PubMed ID: 20137320
[TBL] [Abstract][Full Text] [Related]
30. Nickel Hypersensitivity to Atrial Septal Occluders: Smoke Without Fire?
Apostolos A; Drakopoulou M; Gregoriou S; Synetos A; Trantalis G; Tsivgoulis G; Deftereos S; Tsioufis K; Toutouzas K
Clin Rev Allergy Immunol; 2022 Jun; 62(3):476-483. PubMed ID: 34129170
[TBL] [Abstract][Full Text] [Related]
31. The impact of transcatheter atrial septal defect closure in the older population: a prospective study.
Khan AA; Tan JL; Li W; Dimopoulos K; Spence MS; Chow P; Mullen MJ
JACC Cardiovasc Interv; 2010 Mar; 3(3):276-81. PubMed ID: 20298984
[TBL] [Abstract][Full Text] [Related]
32. Early single clinical experience with the new Figulla ASD Occluder for transcatheter closure of atrial septal defect in adults.
Cansel M; Pekdemir H; Yağmur J; Tasolar H; Ermis N; Kurtoglu E; Acıkgoz N; Atas H; Ozdemir R
Arch Cardiovasc Dis; 2011 Mar; 104(3):155-60. PubMed ID: 21497304
[TBL] [Abstract][Full Text] [Related]
33. Device size for transcatheter closure of ovoid interatrial septal defect.
Cho EH; Song J; Choi EY; Lee SY
Heart Surg Forum; 2013 Aug; 16(4):E193-7. PubMed ID: 23958530
[TBL] [Abstract][Full Text] [Related]
34. Nickel allergy and device closure of the patent foramen ovale, now that we were told should we care?
Meier B
Catheter Cardiovasc Interv; 2009 Oct; 74(4):652. PubMed ID: 19780059
[No Abstract] [Full Text] [Related]
35. Metal allergy, atrial septal occluder devices and the risk of Kounis syndrome.
Kounis NG; Kounis GN; Koutsojannis C; Tsigkas G; Almpanis G; Mazarakis A
Ann Thorac Surg; 2010 Dec; 90(6):2087-8. PubMed ID: 21095381
[No Abstract] [Full Text] [Related]
36. Intermediate term follow-up on transcatheter closure of atrial septal defects by Amplatzer septal occluder.
Durongpisitkul K; Soongswang J; Laohaprasitiporn D; Nana A
J Med Assoc Thai; 2000 Sep; 83(9):1045-53. PubMed ID: 11075972
[TBL] [Abstract][Full Text] [Related]
37. Severe mitral valve insufficiency after transcatheter atrial septal defect closure with the amplatzer septal occluder: a device-related complication.
Li W; Han W; Yu C; Zhang C; Tu Z; Wu S; Huber CH; Ma L
J Card Surg; 2009; 24(6):672-4. PubMed ID: 20078713
[TBL] [Abstract][Full Text] [Related]
38. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.
Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B
Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921
[TBL] [Abstract][Full Text] [Related]
39. Intermediate and long-term outcome of patients after device closure of ASD with special reference to complications.
Kazmi T; Sadiq M; Asif-ur-Rehman ; Hyder N; Latif F
J Ayub Med Coll Abbottabad; 2009; 21(3):117-21. PubMed ID: 20929028
[TBL] [Abstract][Full Text] [Related]
40. Combined prospective United States clinical study data for the GORE(®) HELEX(®) septal occluder device.
Rhodes JF; Goble J
Catheter Cardiovasc Interv; 2014 May; 83(6):944-52. PubMed ID: 23674380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
